MarketPulse

drug approvals

3 articles
The Motley FoolThe Motley Fool··Adria Cimino

Novo Nordisk's Wegovy Dominates Early Oral GLP-1 Race, But Lilly's Foundayo Shows Promise

Novo Nordisk's Wegovy captures 65% of new oral GLP-1 prescriptions with 1.3M scripts written, while Eli Lilly's Foundayo treats 20K+ patients since April approval.
LLYNVOmarket shareweight loss drugs
The Motley FoolThe Motley Fool··James Halley

J&J Shrugs Off Market Turbulence With Defensive Healthcare Appeal

Johnson & Johnson shares dropped under 2% as S&P 500 fell 7%, backed by $94.2B revenue, 6% growth, and 63 consecutive dividend increases, though talc lawsuits and Medicare price negotiations pose headwinds.
JNJPTGXKVUEpharmaceuticalDividend King
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Medidata Earns Top 'Luminary' AI Rating as Solutions Back 80% of FDA Drug Approvals

Medidata secures top 'Luminary' AI rating from Everest Group, supporting 80% of FDA approvals with up to 37% faster patient enrollment.
DASTYagentic AIclinical development